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1. Introduction
The main neuropeptides related to skin neurogenic 
inflammation are the Substance P (SP) and the 
Calcitonin Gene-related Peptide (CGRP) [1-3]. The SP is 
a tachykinin with potent vasodilator properties because 
it stimulates the nitric oxide release by endothelial cells 
[4]. It is often found in sweat glands and in fibers and 
nerve endings of the dermis and epidermis. The SP 
plays important roles in the immune system, in cellular 
and humoral levels, by participating in inflammatory 
processes [5].
CGRP is an amino acid and the most abundant 
neuropeptide in the skin [6]. It is also synthesized from 
the posterior spinal ganglion [7], but in pro-CGRP (15 
kDa) form and, after its cleavage, the CGRP is released 
in nerve endings, in its reactive form (5KDa) [8,9]. 
There are two CGRP isoforms described, α-CGRP 
and β-CGRP [10], although they are functionally quite 
similar. It is the most potent vasodilator known and does 
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Abstract:  Background. The skin neurogenic inflammation is mainly related to Substance P (SP) and Calcitonin Gene-related Peptide (CGRP). 
There is no data on their availability in the dynamics of skin nerve endings, concerning their release and replenishment after 
a nociceptive stimulus, so this was investigated. Materials and methods. 25 rats were randomly distributed in 5 groups. The animals 
of the control group (CG) determined the baseline levels of neuropeptides in the skin. The groups S0 and S30 did not receive any 
cutaneous stimulus at 30 and 60 minutes, respectively. In the group S1, an “incision stimulus” was made at 30 minutes. In the group 
S31, a nociceptive stimulus was performed by subdermal scratching at 30 minutes and, at 60 minutes, the “incision stimulus” was 
carried out in the same location (“nociceptive hyperstimulation”). The skin samples of the other animals were harvested from the back 
1 minute after their death. SP, pro-CGRP and CGRP were quantified by Western Blotting. Results. The “incision stimulus” released SP, 
S1 compared to S0 (p <0.05) detected in the first minute, and the replenishment time was more than 30 minutes. Also, it cleaved 
pro-CGRP, S1 compared to S31 (p <0.05) in the first minute, and its replenishment time less than 30 minutes. Release of CGRP was 
not detected. Conclusion. The incision released SP already detected in the first minute; its replenishment time is more than 30 minutes. 
The incision decreased pro-CGRP, also detected in the first minute; and its replenishment time is less than 30 minutes.
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not involve protein extravasation [11,12]. CGRP also 
modulates cellular and humoral immune properties in 
the skin [13], and its receptors are expressed on many 
inflammatory cells [14], confirming its immunomodulatory 
potential  [15,16].
Both SP and CGRP are frequently present in the 
same nerve fiber, and they are dependent on the Nerve 
Growth Factor [17]. SP induces the co-release of CGRP 
which, in turn, enhance the action of SP although CGRP 
may have long-lasting effects [18,19]. Thus, the release 
of these neuropeptides in the early phase of neurogenic 
inflammation, and its local actions, can determine the 
intensity of the whole inflammatory process of the wound 
healing [18,20,21]. The action of these neuropeptides 
can be ceased, by enzymatic degradation or endocytosis 
(internalization), by the neuropeptide-receptor complex 
in the postsynaptic membrane [22-24].
The neurogenic inflammation has been increasingly 
researched in experimental studies related to wound 
healing [5,25], focusing on these two neuropeptides. 
In the literature there is no satisfactory information 
about the availability of these neuropeptides in the skin. 
It is necessary to understand how is the dynamics of 
nerve ending in the release and replenishment of them 
after a nociceptive stimulus, such as a skin incision. 
Therefore, the present study aims to investigate the 
time required for reaction and replenishment of SP and 
CGRP, so that the nerve endings are functionally able to 
a new nociceptive stimulus in rat skin.
2. Materials and methods
This study is experimental, controlled, randomized, and 
blinded for laboratory analysis. The procedures were 
performed in the Experimental Surgery Laboratory, 
Department of Surgery, Universidade Federal de São 
Paulo–Unifesp, and the biochemical analysis were 
performed at the Neurosurgical Pathophysiology 
Laboratory of the Faculdade de Medicina da 
Universidade de São Paulo-LIM45–FMUSP.
Twenty five male Wistar EPM-1 rats aged 8 weeks, 
weighing between 260 and 300 grams, from the 
Development Center of Experimental Models for 
Medicine and Biology of Unifesp were used. All rats 
were housed in individual cages, receiving appropriate 
common ration and water ad libitum. They remained 
in sleep-wake cycle of 12 hours, with a constant 
temperature of 22°C.
This study was approved by the Research Ethics 
Committee of the Unifesp (number 1910/10), and was 
performed in accordance with the ethical standards by 
the Brazilian Society of Sciences in Laboratory Animals.
2.1 Settings
All animals were randomly distributed into five groups, 
undergoing general anesthesia and hair removal on the 
back, in a standardized way, except those belonging 
to the Control Group (CG). The hair removal of the CG 
was performed after the animals´ sacrifice and then the 
skin samples were harvested. In the animals of groups 
S0 and S30, the skin samples were harvested 30 and 
60 minutes after hair removal, without another prior 
cutaneous stimulus. In the group S1, the animals were 
subjected to “incision stimulus” 30 minutes after hair 
removal. In the group S31, the animals were subjected 
to hyperstimulation of the “incision stimulus” 60 minutes 
after hair removal, and then the skin samples were 
harvested (Figure 1).
2.2 Experimental Procedure
All animals underwent general anesthesia by 
intramuscular application of xylazine hydrochloride 
/ ketamine solution in the ratio of 1:2, respectively, 
and 1 ml kg-1. Then each animal was placed in the 
prone position, immobilized on a board of surgery, and 
the hair removal on dorsal region was performed, in 
a rectangular region centered on the dorsal midline. 
The cranial limit is the transverse plane at the scapular 
superior angle. The caudal limit is the transverse plane 
in the lower portion of iliac crests, comprising an area 
of 12 cm x 6 cm (Figure 2). The hair removal was 
performed using an electric hair cutting machine (8267 
Pro Basic, Wahl® brand, 60Hz, 10W).
The sacrifice of the animals (assisted painless death) 
belonging to CG was performed and, only then, they 
were submitted to hair removal; and after one minute, 
the skin sample was harvested up. In the other groups, 
hair removal was performed in vivo and the skin sample 
was harvested one minute after the sacrifice of animals, 
and after each procedure related.
The animals belonging to the group S0 were 
sacrificed 30 minutes after hair removal. The skin sample 
was harvested one minute later. A similar procedure was 
carried out in relation to the Group S30, but with a hold 
time of 60 minutes after hair removal. In the group S1, 
it was held the “incision stimulus” 30 minutes after hair 
removal, by surgical blade (number 15), in a straight 
line segment 3 cm long on the dorsal midline starting 
from 5 cm of the transverse line between the scapular 
inferior angles, in the cranial-caudal direction. The skin 
of interest extends until the superficial fascia (Figure 3). 
The animals belonging to the group S31 were submitted 
to hyperstimulation of “incision stimulus”, which 
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consisted of a linear scratch of the subdermal plane, 
in the same location of the line segment described 
above, 30 minutes after hair removal, and the “incision 
stimulus” itself after 60 minutes. The scratch was 
performed by the bezel of a hypodermic needle 40 x 12 
mm (18G x 1½“) introduced into the caudal point of the 
line segment, after conducting three abrasion incursions 
in the cranial – caudal direction, without transposing the 
needle through the epidermis (Figure 4).
2.3 Obtaining samples
After sacrifice each animal was firmly held on the caudal 
and cranial extremities of the trunk, arching it so as to 
keep the dorsal skin stretched out and exposed. Using 
an electric dermatome, a partial skin fragment with 
a thickness of 500 μm was removed, measuring 
2x2 cm. To obtain the skin sample, an 8 mm punch 
was used at the center of this fragment. The samples 
were immediately placed in dry 2.0 ml Eppendorff 
tubes, immediately frozen on dry ice, and kept at 
-20°C until analysis of these neuropeptides in the 
obtained samples.
2.4 Western blot analysis
Tissues samples were individually homogenized 
in lyses buffer containing 1% NP40 (Sigma), 0.5% 
sodium deoxycholate (Sigma), 1% SDS (Sigma), 
1mM L-1 EDTA (Sigma), 1mM L-1 EGTA (Sigma), and 1% 
protease inhibitor cocktail (Sigma) diluted in phosphate 
buffered saline (PBS, pH 7.4) and then sonicated. 
Figure 1. Allocation of the study groups.
Figure 2. Model of rat hair removal. Figure 3. Model of “incision stimulus”.
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The homogenate was centrifuged (14,000 rpm) for 30 
min at 4°C [26,27]; supernatants were transferred into 
new tubes and stored at -70°C until use.
Protein concentrations were determined according 
to the method described by Bradford [28]. The samples 
(60mg of protein/lane) were separated on a 12% sodium 
dodecyl sulfate (SDS)-polyacrylamide (Bio-Rad) by 
electrophoresis gel at 100 V for one hour.
Proteins were transferred to polyvinylidene fluoride 
(PVDF) membranes (Bio-Rad) for one hour to 100 V. 
After transference the membranes were blocked with 
10% milk diluted in TBS-T (mixture of Tris-Buffered 
Saline and 0.05% Tween 20) for 15 minutes under slight 
agitation at room temperature. Then, all membranes 
were incubated with goat antibody to SP (1:100 in 3% 
milk/TBS-T, Sigma) or rabbit antibody to CGRP (1:300; 
Sigma) overnight at 4°C.
Membranes were washed twice for 10 minutes in 
TBS-T and incubated at room temperature for 1 hour 
with anti-goat or anti-rabbit conjugated secondary 
antiserum (1:10,000-1:2,000, respectively; Amersham 
Biosciences, UK). Blots were washed two times 
with TBS-T and once TBS. After final washes, the 
membrane was incubated with Western Lightning 
Chemiluminescence Reagent Plus (PerkinElmer Life 
Science, USA) for 1 minute. The membranes were 
exposed to an X-ray film for imaging (Hyperfilm™ ECL, 
Amersham Biosciences, USA) to visualize protein 
bands. After this blots were stripped, blocked and 
incubated with rabbit antibody to β-actin (1:30,000 in 3% 
milk/TBS-T, Sigma) during 1 hour at room temperature 
and developed as previously described.
The films were scanned (HP Scanjet G4000 series) 
and SP and CGRP protein levels were quantified by 
densitometry by means of a computer-assisted image 
analyzer using Image J software (version 1.43u, National 
Institute of Health, USA). Density normalization was 
done dividing the proteins by β-tubulin III density values
3. Results
The stimulation in 30 minutes (S1) released SP (p <0.05) 
compared to the same period without stimulation (S0), 
and the replenishment time of this neuropeptide was 
greater than 30 minutes (Figure 5).
As for CGRP, the stimulation in 30 minutes (S1) and 
the hyperstimulation (S31) at 60 minutes consumed 
the pro-CGRP (15 kDa) (p<0.05), but there was no 
difference in the amount of this neuropeptide between 
the groups (graphic 2). The replenishment time of this 
neuropeptide was less than 30 minutes (Figure 6). 
The reactive form (5 kDa) had no significant difference 
between the groups (Figure 7).
Figure 4. Linear scratch of the subdermal plane in the same loca-
tion of the previous “incision stimulus”: hyperstimulation 
of “incision stimulus”.
Figure 5. SP values found for each group.
Figure 6. Pro-CGRP values found for each group.
Figure 7. CGRP values found for each group.
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4. Discussion
The neurogenic inflammation is triggered by different 
types of nociceptive stimuli on the skin by the activation 
of dermal-epidermal sensory nerve fibers [5,25,29]. 
Didactically it can be divided into neuroelectric and 
neuropeptidergic components. The first occurs 
immediately after the skin wound, with the conduction 
of electrical impulses from the injury site, in dromic 
direction, by the “current of injury” generation. The second 
component consists of neuropeptides release through 
nerve endings in the skin, in dromic direction [30,31].
Neuropeptides which are in the presynaptic terminals, 
within the nerve ending, are considered, a priori, ready to 
undergo exocytosis. The axonal reflex, when released, 
moves in dromic direction more neuropeptides to be 
released again, recharging the nerve fiber [23,32]. This 
reflex takes place in an interval in which, even the skin 
receiving new stimuli, probably there is no release of 
neuropeptide anymore until the fiber receives a minimum 
replenishment, adequate for a new response [33,34]. 
This reaction and replenishment time were the topics that 
guided the present study.
Of all the skin free nerve endings, especially type 
C fibers, about 95% are intradermal and 5% epidermal 
[35]. However, the largest neuropeptides stock is located 
in the deeper dermis, in the vascular plexus level, in 
the body of sweat glands, and in pilo-sebaceous units 
[36]. In a skin incision, as the release of neuropeptides 
occurs in small amounts by nerve endings, unlike 
neurotransmitters [25], the chosen option was to study 
only the most superficial epidermis and dermis, by using 
an electric dermatome in collecting skin samples. Thus, 
when the sample quantification was performed using 
the Western Blotting (WB) method, it would be avoided 
a flood of neuropeptides that were not directly involved 
to the nociceptive stimulus provoked, which could 
compromise the sensitivity of this method for this type of 
measurement. In this context, the WB would quantify the 
amount of neuropeptides contained in the whole sample, 
either inside the nerve endings or those already free in 
the synaptic cleft.
In the absence of any reference in the literature about 
the effect of hair removal in the release of SP and CGRP, 
it was decided to perform the trichotomy, on CG, after the 
animals death because the quantities of neuropeptides 
obtained would correspond to the baseline state of the 
skin. In the other groups, procedures, including trichotomy, 
were performed in vivo, and a period of 30 minutes was 
observed as safety margin. There is a hiatus in the 
literature regarding the release of neuropeptides by hair 
removal; however, it is assumed that it probably occurs, 
as well as nociceptive stimuli, mechanical stimuli also 
release them [38]. Therefore, in this study, 30 minutes 
were waited after hair removal because Grant et al. found 
that CGRP remains active and is not degraded in the skin 
for at least 30 minutes, even in the co-injection of SP [39].
The “incision stimulus” was enough to release SP from 
nerve endings (S1) in one minute; and because there 
was no difference between the S31 and S30 groups, it 
can be deduced that the scratch stimulus released SP, 
and 30 minutes was not enough time for a functional 
replenishment of the nerve ending so that reach the 
release level achieved in the animals belonging to group 
S1, after “incision stimulus”. Thus, the replenishment 
time for SP was greater than 30 minutes. Thus, these 
data confirm that, as expected, the scratch stimulus was 
sufficiently to deplete SP; and 30 minutes, relatively 
long period, was not enough time for a functional 
replenishment of the nerve ending. This period of time 
supports the importance of SP nociceptive sensitization 
after an incision, and potentially participates directly in 
modulating the intensity of inflammatory response in peri-
incisional tissue [37].
As for the pro-CGRP (15 kDa), it showed decreased 
amount after stimulus by an incision in one minute (S1), 
that is, it was cleaved to give the CGRP in its active 
form (5 kDa). Analogous to the S31 group for SP, the 
S31 group for pro-CGRP had no difference regarding the 
S1 group, therefore, the hyperstimulation did not cause 
further cleavage of this substance, and then cleavage 
levels are similar. Two hypotheses can be attributed 
to this fact: according to the first, and the most likely, 
analogously to SP, the stimulus with a needle also 
cleaved CGRP, and 30 minutes was enough time so that 
nerve endings become apt again to the cleavage of this 
neuropeptide to a new stimulus. The second hypothesis, 
the less likely, in the case of pro-CGRP, paradoxically to 
the SP, the scratch stimulus did not cleaved pro-CGRP 
and, in this case, it would not be possible to detect the 
replenishment time to pro-CGRP in nerve endings. 
However, conceptually [38,40], nociceptive stimuli 
release neuropeptides in a global way and, in the case 
of SP and CGRP one co-releases another in the same 
nerve ending. Thus, it would be really unlikely the second 
hypothesis. It can be inferred, therefore, that pro-CGRP 
is replenished to functional levels in a time period below 
30 minutes (S31). On the other hand, in the present 
study, CGRP showed no changes in their amounts in 
several studied groups, remaining relatively constant 
basal levels. However, as the pro-CGRP was cleaved 
into CGRP, it would be expected an increased amount 
of this. In a different way of SP, the present study was 
not able to determine the moment of increased amounts 
thereof in 30 or 60 minutes.
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This context is grounded in the literature since CGRP 
is one of the most potent vasodilators identified so far, 
with a particularly long duration, lasting several hours in 
human [41] and rodent skin [42]. Its intravascular half-
life is only 7 minutes [43], suggesting that it is rapidly 
metabolized in the blood. However, it is unclear whether 
this difference is due to greater CGRP stability in the 
skin or to an alternative mechanism. More researches 
must be done in understanding the chronology of the 
availability of skin neuropeptides.
In conclusion, the skin stimulation with an incision 
released SP and that release was detected in the first 
minute; and the sufficient time for its replenishment so 
that nerve endings are functional to a new release of 
neuropeptide is greater than 30 minutes. The incision 
decreased the amount of pro-CGRP from nerve endings, 
also detected in the first minute, and its functional 
replenishment occurred in a period of less than 30 
minutes.
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